Concord Biotech Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 | Sep-26 |
|---|---|---|---|---|---|---|---|---|
| 244 | 430 | 204 | 247 | 278 | 326 | 257 | 309 | |
| 15 | 9 | 14 | 13 | 10 | 15 | 13 | 10 | |
| 160 | 254 | 160 | 177 | 198 | 227 | 193 | 223 | |
| 61 | 80 | 60 | 57 | 67 | 71 | 70 | 64 | |
| 12 | 10 | 13 | 14 | 20 | 16 | 11 | 16 | |
| −21 | 38 | −28 | −22 | −21 | −0.40 | −27 | −6 | |
| 35 | 39 | 38 | 44 | 47 | 48 | 44 | 52 | |
| 0.10 | 0.10 | 0.06 | 0.06 | 0.08 | 0.08 | 0.04 | 0.03 | |
| 13 | 15 | 18 | 18 | 19 | 20 | 18 | 18 | |
| 59 | 72 | 60 | 65 | 66 | 74 | 77 | 79 | |
| 113 | 200 | 75 | 102 | 106 | 134 | 95 | 115 | |
| 99 | 185 | 57 | 83 | 87 | 114 | 77 | 96 | |
| — | — | — | — | −3 | — | — | — | |
| 99 | 185 | 57 | 83 | 87 | 114 | 77 | 96 | |
| 25 | 43 | 15 | 23 | 23 | 26 | 21 | 26 | |
| 76 | 140 | 44 | 63 | 64 | 88 | 58 | 70 | |
| Financial ratios | ||||||||
| 46.14% | 46.48% | 36.81% | 41.22% | 38.05% | 41.05% | 36.98% | 37.06% | |
| 31.09% | 32.66% | 21.60% | 25.52% | 22.91% | 27.13% | 22.41% | 22.51% | |
| 7.26 | 13.42 | 4.21 | 6.03 | 6.08 | 8.46 | 5.52 | 6.65 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.